Jennifer Buell - Jun 11, 2024 Form 3 Insider Report for AGENUS INC (AGEN)

Role: Chairman Executive Council, Director
Signature: Christine M. Klaskin, by Power of Attorney
Stock symbol: AGEN
Transactions as of: Jun 11, 2024
Transactions value $: $0
Form type: 3
Date filed: 6/20/2024, 04:05 PM
Previous filing: Mar 29, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AGEN	Common Stock						13.7K	Jun 11, 2024	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	1.23K	$100.80	Direct
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	525	$100.80	Direct
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	5K	$83.20	Direct
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	6.25K	$75.40	Direct
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	6.5K	$41.40	Direct
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	15K	$47.60	Direct
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	25K	$82.40	Direct
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	500	$72.20	Direct
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	45K	$74.00	Direct
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	45K	$63.60	Direct	F1
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	7.5K	$64.40	Direct	F2
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	37.5K	$47.40	Direct	F3
holding	AGEN	Stock Option, right to buy							Jun 11, 2024	Common Stock	37.5K	$11.80	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended) and vests over four years with one third vesting on the 2-year anniversary of the grant date (January 1, 2021) and the balance in equal quarterly installments thereafter.
F2	Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended) and vests over three years with one third vesting on the one year anniversary of the grant date (January 1, 2022) and the balance in equal quarterly installments thereafter.
F3	Options awarded in accordance with the Agenus Inc. 2019 Equity Incentive Plan (as amended) and vests over three years with one third vesting on the one year anniversary of the grant date (January 9, 2023) and the balance in equal quarterly installments thereafter.
F4	Options were granted on January 17, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 16, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 750,000 Stock Options with an exercise price of $0.59..